Vascular access problems in dialysis patients: Pathogenesis and strategies for management

Heart Disease

Volumn 3, Issue 4, 2001, Pages 242-247

  Joseph, S ^a   Adler, S ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

Access thrombosis; Dialysis access; Hemodialysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; TICLOPIDINE;

ANGIOGRAPHY; ANGIOPLASTY; ARTERIOVENOUS FISTULA; BLOOD VESSEL GRAFT; HEMODIALYSIS; HUMAN; PATHOGENESIS; REVIEW; STENOSIS; THROMBOSIS; TREATMENT PLANNING; VASCULAR ACCESS; VASCULAR DISEASE; VASCULAR SURGERY;

EID: 0035199967     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200107000-00007     Document Type: Review

References (68)

1. Cannulation of blood vessels for prolonged hemodialysis
2. Chronic hemodialysis using venipuncture and a surgically created AV fistula
3. Saphenons vein AV fistula in regular dialysis treatment
4. Experience with arterial substitutes in the construction of vascular access for hemodialysis
5. Expanded polytetrafluoroethylcne (PTFE) subcutaneous AV conduit: An improved vascular access for hemodialysis
6. Comparison of "PTFE" and bovine grafts for blood access in hemodialysis patients
7. Successful use of double, lumen, silicone rubber catheters for permanent hemodialysis access
8. Access for hemodialysis by means of long-term central venous catheters
9. Nine years' experience with internal AV fistulas for hemodialysis: A study of some factors influencing the results
10. Predictors of adequacy of AV fistulas in hemodialysis patients
11. Vascular access for hemodialysis: Patency rates and results of revision
12. Vascular access survival among incident hemodialysis patients in the United States
13. Vascular access: Concepts for the 1990s
14. Comparison of autogenous fistula versus expanded polytetrafluorethylene graft fistula for angioaccess in hemodialysis
15. Prospective evaluation of a dacron cuffed hemodialysis catheter for prolonged use
16. Hemodialysis vascular access morbidity in the United States
17. Timing of nephrology referral: Influence on mortality and morbidity
18. Permanent vascular access: A nephrologist's view
19. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenosis prior to thrombosis
20. Dialysis access grafts: Anatomic location of venous stenosis and results of angioplasty
21. Optimization of high efficiency dialysis by detection and correction of vascular access dysfunction
22. Percutaneous angioplasty for the treatment of venous stenosis: A nephrologists view
23. Prevention of hemodialysis fistula thrombosis: Early detection of venous stenosis
24. Assessing the adequacy of vascular access and its relationship to patient outcome
25. Hemodialysis associated subclavian vein stenosis
26. Vascular access for hemodialysis
27. Intimal fibro muscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients
28. Vascular access stenosis: Prospects for prevention and therapy
29. The effects of hemodialysis on platelet deposition in prosthetic graft fistulas
30. Aspirin enhances platelet derived growth factor-induced vascular smooth muscle cell proliferation
31. Elevated erythropoietin receptor and transforming growth factor-β1 expression in stenotic AV fistulae used for hemodialysis
32. Anticardiolipin antibodies are associated with stenosis of vascular access in patients receiving hemodialysis
33. Antibodies to topical bovine thrombin correlate with access thrombosis
34. Changes in venous histology in chronic hemodialysis patients
35. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenosis prior to thrombosis
36. Prolongation of hemodialysis access survival with elective revision
37. Prevention of hemodialysis fistula thrombosis: Early detection of venous stenoses
38. Monitoring interposition graft venous pressures at higher blood-flow rates improves sensitivity in predicting graft failure
39. Simplified measurement of intra-access pressure
40. Predictive measures of vascular access thrombosis: A prospective study
41. Change in access blood flow over time predicts vascular access thrombosis
42. Graft flow as a predictor of thrombosis in hemodialysis grafts
43. Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting
44. Accuracy of Doppler ultrasound in diagnosing anatomic stenosis of hemodialysis AV access as compared with fistulography
45. Reduction in AV graft impairment: Results of a vascular access surveillance protocol
46. A multidisciplinary approach to hemodialysis access: Prospective evaluation
47. Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis
48. Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene AV grafts: Results of a prospective randomized study
49. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
50. Insufficient dialysis shunts: Improved long term patency rates with close hemodynamic monitoring, repeated percutaneous balloon angioplasty and stent placement
51. Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts
52. Treatment of hemodialysis-related central venous stenosis or occlusion, results of primary wall stent placement and follow-up in 50 patients
53. Pulsed-spray pharmacomechanical thrombolysis of thrombosed hemodialysis grafts: Long-term experience and comparison of original and current techniques
54. Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts
55. Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts
56. Mechanical thrombolysis for the treatment of thrombosed dialysis access grafts: Report of a series
57. Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts
58. Treatment of failing and failed hemodialysis access sites: Comparison of surgical treatment with thrombolysis/angioplasty
59. Surgical management of thrombosed dialysis access grafts
60. Thrombolysis versus thrombectomy for occluded hemodialysis grafts
61. Effects of anti-platelet drugs on dialysis associates platelet deposition in PTFE grafts
62. Dipyridamole inhibits PDGF and bFGF-induced vascular smooth muscle cell proliferation
63. Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study
64. Collaborative overview of randomised trials of antiplatelet therapy-II maintenance of vascular graft or arterial patency by antiplatelet therapy
65. Brachytherapy for the prevention of stenosis in a canine hemodialysis graft model: Preliminary observations